Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,200,770
-
Share change
-
+585,382
-
Total reported value
-
$1,518,639,850
-
Put/Call ratio
-
91%
-
Price per share
-
$60.27
-
Number of holders
-
111
-
Value change
-
+$35,212,599
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2013
As of 31 Dec 2013,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,200,770 shares.
The largest 10 holders included
FMR LLC, Partner Fund Management, L.P., NEA Management Company, LLC, VANGUARD GROUP INC, SAC Capital Advisors LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, CLIFTON PARK CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., and D. E. Shaw & Co., Inc..
This page lists
111
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.